Compare Biocon Ltd with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ALEMBIC PHARMA - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON ALEMBIC PHARMA BIOCON /
ALEMBIC PHARMA
 
P/E (TTM) x 30.2 21.0 143.7% View Chart
P/BV x 3.9 6.2 62.6% View Chart
Dividend Yield % 0.3 0.6 41.2%  

Financials

 BIOCON    ALEMBIC PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-19
ALEMBIC PHARMA
Mar-19
BIOCON /
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs707664 106.5%   
Low Rs554412 134.3%   
Sales per share (Unadj.) Rs91.9208.7 44.0%  
Earnings per share (Unadj.) Rs16.731.0 53.9%  
Cash flow per share (Unadj.) Rs24.237.1 65.1%  
Dividends per share (Unadj.) Rs1.005.50 18.2%  
Dividend yield (eoy) %0.21.0 15.5%  
Book value per share (Unadj.) Rs101.6144.2 70.5%  
Shares outstanding (eoy) m600.00188.52 318.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.92.6 266.1%   
Avg P/E ratio x37.717.4 217.3%  
P/CF ratio (eoy) x26.114.5 179.9%  
Price / Book Value ratio x6.23.7 166.3%  
Dividend payout %6.017.7 33.7%   
Avg Mkt Cap Rs m378,330101,461 372.9%   
No. of employees `0006.1NA-   
Total wages/salary Rs m11,6537,467 156.1%   
Avg. sales/employee Rs Th8,994.3NM-  
Avg. wages/employee Rs Th1,900.7NM-  
Avg. net profit/employee Rs Th1,635.3NM-  
INCOME DATA
Net Sales Rs m55,14439,347 140.1%  
Other income Rs m1,44494 1,539.4%   
Total revenues Rs m56,58839,441 143.5%   
Gross profit Rs m15,8838,736 181.8%  
Depreciation Rs m4,4781,152 388.6%   
Interest Rs m709184 385.1%   
Profit before tax Rs m12,1407,493 162.0%   
Minority Interest Rs m911 83.3%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1231,568 135.4%   
Profit after tax Rs m10,0265,844 171.6%  
Gross profit margin %28.822.2 129.7%  
Effective tax rate %17.520.9 83.6%   
Net profit margin %18.214.9 122.4%  
BALANCE SHEET DATA
Current assets Rs m48,22819,577 246.3%   
Current liabilities Rs m30,37614,896 203.9%   
Net working cap to sales %32.411.9 272.1%  
Current ratio x1.61.3 120.8%  
Inventory Days Days6890 76.1%  
Debtors Days Days8645 188.5%  
Net fixed assets Rs m64,13027,097 236.7%   
Share capital Rs m3,000377 795.8%   
"Free" reserves Rs m57,98026,811 216.3%   
Net worth Rs m60,98027,188 224.3%   
Long term debt Rs m15,7664,993 315.8%   
Total assets Rs m121,92447,778 255.2%  
Interest coverage x18.141.7 43.5%   
Debt to equity ratio x0.30.2 140.8%  
Sales to assets ratio x0.50.8 54.9%   
Return on assets %8.812.6 69.8%  
Return on equity %16.421.5 76.5%  
Return on capital %16.823.6 71.0%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Exports (fob) Rs m15,506NA-   
Imports (cif) Rs m10,399NA-   
Fx inflow Rs m15,50619,453 79.7%   
Fx outflow Rs m10,3996,065 171.5%   
Net fx Rs m5,10713,388 38.1%   
CASH FLOW
From Operations Rs m11,5468,120 142.2%  
From Investments Rs m-7,138-7,556 94.5%  
From Financial Activity Rs m-2,417590 -409.4%  
Net Cashflow Rs m2,1031,153 182.3%  

Share Holding

Indian Promoters % 40.4 74.1 54.5%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 2.9 289.7%  
FIIs % 10.7 9.1 117.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 13.9 143.2%  
Shareholders   109,995 49,328 223.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 178 Points Higher; Telecom and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest throughout the day today and ended on a positive note.

Related Views on News

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jul 3, 2020 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS